Archive - February 2022
FDA Approves Pyrukynd (mitapivat) as First Disease-Modifying Therapy for Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency
‘Endemic Delusion’: Why Experts Feel It’s Too Soon To Remove COVID Restrictions
Gilead shares results from HIV trial for lenacapavir
Eli Lilly partners with breast cancer advocacy organisations to raise awareness of risk factors
Seal of Approval: Direct-to-PCR COVID-19 test in the UK validated
Moderna’s commercial network grows
The past, present and future of antiviral discovery
Dogs Can Be Trained To Sniff Out COVID-19 — A Team Of Forensic Researchers Explain The Science